We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Santosh Kesari

Santosh Kesari MD, PhD, FANA, FAAN

Professor and Chair, Department of Translational Neuro-Oncology and Neurotherapeutics, John Wayne Cancer Institute; Director, Neuro-Oncology, Providence St. John’s Health Center, Santa Monica, California

Dr. Santosh Kesari is the Chair of the Department of Translational Neuro-Oncology and Neurotherapeutics at the John Wayne Cancer Institute and Director of Neuro-Oncology at Providence St. John’s Health Center in Santa Monica, California. A Fellow of the American Neurological Association (FANA) and a Fellow of the American Academy of Neurology (FAAN), he is a member of the Los Angeles Biomedical Research Institute.

Dr. Kesari is very active in basic and translational research and clinical research. His research program is focused on understanding the developmental and molecular aberrations resulting in malignant gliomas and using this information to develop novel molecular therapeutics to improve patient survival. He has published his research in over 160 articles in peer-reviewed journals.

Dr. Kesari was awarded his medical degree from the University of Pennsylvania, where he also earned a PhD in molecular biology. He was a resident in neurology at the Partners Neurology Residency Program of the Massachusetts General and Brigham and Women’s hospitals, Boston, Massachusetts, after which he completed a clinical fellowship in neuro-oncology at the Dana-Farber Cancer Institute/Massachusetts General Hospital/Brigham and Women's Hospital in Boston.

He is a member of the Society for Neuroscience, American Academy of Neurology, American Society of Clinical Oncology, American Association for Cancer Research among other professional organizations. He is a peer reviewer for over 100 national and international scientific journals and serves on a number of editorial review boards.